Global Endometriosis Therapies Market Size, Status and Forecast 2020-2026

May 2020 | 97 pages | ID: G61FF5A8B64BEN
QYResearch

Abstracts

This report focuses on the global Endometriosis Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Endometriosis Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• AbbVie
• Eli Lilly
• AstraZeneca
• Bayer
• Astellas Pharma
• Meditrina Pharmaceuticals
• Pfizer
• Neurocrine Biosciences
• Takeda Pharmaceutical

Market segment by Type, the product can be split into

• Hormonal Contraceptives
• Gonadotropin-releasingHormone(Gn-RH)Agonists
• Progestin Therapy
• Aromatase Inhibitors

Market segment by Application, split into

• Hospital
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Endometriosis Therapies status, future forecast, growth opportunity, key market and key players.
• To present the Endometriosis Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Endometriosis Therapies are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Endometriosis Therapies Revenue
1.4 Market Analysis by Type
  1.4.1 Global Endometriosis Therapies Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Hormonal Contraceptives
  1.4.3 Gonadotropin-releasingHormone(Gn-RH)Agonists
  1.4.4 Progestin Therapy
  1.4.5 Aromatase Inhibitors
1.5 Market by Application
  1.5.1 Global Endometriosis Therapies Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Endometriosis Therapies Market Perspective (2015-2026)
2.2 Endometriosis Therapies Growth Trends by Regions
  2.2.1 Endometriosis Therapies Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Endometriosis Therapies Historic Market Share by Regions (2015-2020)
  2.2.3 Endometriosis Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Endometriosis Therapies Market Growth Strategy
  2.3.6 Primary Interviews with Key Endometriosis Therapies Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Endometriosis Therapies Players by Market Size
  3.1.1 Global Top Endometriosis Therapies Players by Revenue (2015-2020)
  3.1.2 Global Endometriosis Therapies Revenue Market Share by Players (2015-2020)
  3.1.3 Global Endometriosis Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Endometriosis Therapies Market Concentration Ratio
  3.2.1 Global Endometriosis Therapies Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Endometriosis Therapies Revenue in 2019
3.3 Endometriosis Therapies Key Players Head office and Area Served
3.4 Key Players Endometriosis Therapies Product Solution and Service
3.5 Date of Enter into Endometriosis Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Endometriosis Therapies Historic Market Size by Type (2015-2020)
4.2 Global Endometriosis Therapies Forecasted Market Size by Type (2021-2026)

5 ENDOMETRIOSIS THERAPIES BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Endometriosis Therapies Market Size by Application (2015-2020)
5.2 Global Endometriosis Therapies Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Endometriosis Therapies Market Size (2015-2020)
6.2 Endometriosis Therapies Key Players in North America (2019-2020)
6.3 North America Endometriosis Therapies Market Size by Type (2015-2020)
6.4 North America Endometriosis Therapies Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Endometriosis Therapies Market Size (2015-2020)
7.2 Endometriosis Therapies Key Players in Europe (2019-2020)
7.3 Europe Endometriosis Therapies Market Size by Type (2015-2020)
7.4 Europe Endometriosis Therapies Market Size by Application (2015-2020)

8 CHINA

8.1 China Endometriosis Therapies Market Size (2015-2020)
8.2 Endometriosis Therapies Key Players in China (2019-2020)
8.3 China Endometriosis Therapies Market Size by Type (2015-2020)
8.4 China Endometriosis Therapies Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Endometriosis Therapies Market Size (2015-2020)
9.2 Endometriosis Therapies Key Players in Japan (2019-2020)
9.3 Japan Endometriosis Therapies Market Size by Type (2015-2020)
9.4 Japan Endometriosis Therapies Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Endometriosis Therapies Market Size (2015-2020)
10.2 Endometriosis Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Endometriosis Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Endometriosis Therapies Market Size by Application (2015-2020)

11 INDIA

11.1 India Endometriosis Therapies Market Size (2015-2020)
11.2 Endometriosis Therapies Key Players in India (2019-2020)
11.3 India Endometriosis Therapies Market Size by Type (2015-2020)
11.4 India Endometriosis Therapies Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Endometriosis Therapies Market Size (2015-2020)
12.2 Endometriosis Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Endometriosis Therapies Market Size by Type (2015-2020)
12.4 Central & South America Endometriosis Therapies Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AbbVie
  13.1.1 AbbVie Company Details
  13.1.2 AbbVie Business Overview and Its Total Revenue
  13.1.3 AbbVie Endometriosis Therapies Introduction
  13.1.4 AbbVie Revenue in Endometriosis Therapies Business (2015-2020))
  13.1.5 AbbVie Recent Development
13.2 Eli Lilly
  13.2.1 Eli Lilly Company Details
  13.2.2 Eli Lilly Business Overview and Its Total Revenue
  13.2.3 Eli Lilly Endometriosis Therapies Introduction
  13.2.4 Eli Lilly Revenue in Endometriosis Therapies Business (2015-2020)
  13.2.5 Eli Lilly Recent Development
13.3 AstraZeneca
  13.3.1 AstraZeneca Company Details
  13.3.2 AstraZeneca Business Overview and Its Total Revenue
  13.3.3 AstraZeneca Endometriosis Therapies Introduction
  13.3.4 AstraZeneca Revenue in Endometriosis Therapies Business (2015-2020)
  13.3.5 AstraZeneca Recent Development
13.4 Bayer
  13.4.1 Bayer Company Details
  13.4.2 Bayer Business Overview and Its Total Revenue
  13.4.3 Bayer Endometriosis Therapies Introduction
  13.4.4 Bayer Revenue in Endometriosis Therapies Business (2015-2020)
  13.4.5 Bayer Recent Development
13.5 Astellas Pharma
  13.5.1 Astellas Pharma Company Details
  13.5.2 Astellas Pharma Business Overview and Its Total Revenue
  13.5.3 Astellas Pharma Endometriosis Therapies Introduction
  13.5.4 Astellas Pharma Revenue in Endometriosis Therapies Business (2015-2020)
  13.5.5 Astellas Pharma Recent Development
13.6 Meditrina Pharmaceuticals
  13.6.1 Meditrina Pharmaceuticals Company Details
  13.6.2 Meditrina Pharmaceuticals Business Overview and Its Total Revenue
  13.6.3 Meditrina Pharmaceuticals Endometriosis Therapies Introduction
  13.6.4 Meditrina Pharmaceuticals Revenue in Endometriosis Therapies Business (2015-2020)
  13.6.5 Meditrina Pharmaceuticals Recent Development
13.7 Pfizer
  13.7.1 Pfizer Company Details
  13.7.2 Pfizer Business Overview and Its Total Revenue
  13.7.3 Pfizer Endometriosis Therapies Introduction
  13.7.4 Pfizer Revenue in Endometriosis Therapies Business (2015-2020)
  13.7.5 Pfizer Recent Development
13.8 Neurocrine Biosciences
  13.8.1 Neurocrine Biosciences Company Details
  13.8.2 Neurocrine Biosciences Business Overview and Its Total Revenue
  13.8.3 Neurocrine Biosciences Endometriosis Therapies Introduction
  13.8.4 Neurocrine Biosciences Revenue in Endometriosis Therapies Business (2015-2020)
  13.8.5 Neurocrine Biosciences Recent Development
13.9 Takeda Pharmaceutical
  13.9.1 Takeda Pharmaceutical Company Details
  13.9.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
  13.9.3 Takeda Pharmaceutical Endometriosis Therapies Introduction
  13.9.4 Takeda Pharmaceutical Revenue in Endometriosis Therapies Business (2015-2020)
  13.9.5 Takeda Pharmaceutical Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Endometriosis Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Endometriosis Therapies Revenue
Table 3. Ranking of Global Top Endometriosis Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Endometriosis Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hormonal Contraceptives
Table 6. Key Players of Gonadotropin-releasingHormone(Gn-RH)Agonists
Table 7. Key Players of Progestin Therapy
Table 8. Key Players of Aromatase Inhibitors
Table 9. Global Endometriosis Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Endometriosis Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Endometriosis Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Endometriosis Therapies Market Share by Regions (2015-2020)
Table 13. Global Endometriosis Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Endometriosis Therapies Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Endometriosis Therapies Market Growth Strategy
Table 19. Main Points Interviewed from Key Endometriosis Therapies Players
Table 20. Global Endometriosis Therapies Revenue by Players (2015-2020) (Million US$)
Table 21. Global Endometriosis Therapies Market Share by Players (2015-2020)
Table 22. Global Top Endometriosis Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Therapies as of 2019)
Table 23. Global Endometriosis Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Endometriosis Therapies Product Solution and Service
Table 26. Date of Enter into Endometriosis Therapies Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Endometriosis Therapies Market Size by Type (2015-2020) (Million US$)
Table 29. Global Endometriosis Therapies Market Size Share by Type (2015-2020)
Table 30. Global Endometriosis Therapies Revenue Market Share by Type (2021-2026)
Table 31. Global Endometriosis Therapies Market Size Share by Application (2015-2020)
Table 32. Global Endometriosis Therapies Market Size by Application (2015-2020) (Million US$)
Table 33. Global Endometriosis Therapies Market Size Share by Application (2021-2026)
Table 34. North America Key Players Endometriosis Therapies Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Endometriosis Therapies Market Share (2019-2020)
Table 36. North America Endometriosis Therapies Market Size by Type (2015-2020) (Million US$)
Table 37. North America Endometriosis Therapies Market Share by Type (2015-2020)
Table 38. North America Endometriosis Therapies Market Size by Application (2015-2020) (Million US$)
Table 39. North America Endometriosis Therapies Market Share by Application (2015-2020)
Table 40. Europe Key Players Endometriosis Therapies Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Endometriosis Therapies Market Share (2019-2020)
Table 42. Europe Endometriosis Therapies Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Endometriosis Therapies Market Share by Type (2015-2020)
Table 44. Europe Endometriosis Therapies Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Endometriosis Therapies Market Share by Application (2015-2020)
Table 46. China Key Players Endometriosis Therapies Revenue (2019-2020) (Million US$)
Table 47. China Key Players Endometriosis Therapies Market Share (2019-2020)
Table 48. China Endometriosis Therapies Market Size by Type (2015-2020) (Million US$)
Table 49. China Endometriosis Therapies Market Share by Type (2015-2020)
Table 50. China Endometriosis Therapies Market Size by Application (2015-2020) (Million US$)
Table 51. China Endometriosis Therapies Market Share by Application (2015-2020)
Table 52. Japan Key Players Endometriosis Therapies Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Endometriosis Therapies Market Share (2019-2020)
Table 54. Japan Endometriosis Therapies Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Endometriosis Therapies Market Share by Type (2015-2020)
Table 56. Japan Endometriosis Therapies Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Endometriosis Therapies Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Endometriosis Therapies Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Endometriosis Therapies Market Share (2019-2020)
Table 60. Southeast Asia Endometriosis Therapies Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Endometriosis Therapies Market Share by Type (2015-2020)
Table 62. Southeast Asia Endometriosis Therapies Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Endometriosis Therapies Market Share by Application (2015-2020)
Table 64. India Key Players Endometriosis Therapies Revenue (2019-2020) (Million US$)
Table 65. India Key Players Endometriosis Therapies Market Share (2019-2020)
Table 66. India Endometriosis Therapies Market Size by Type (2015-2020) (Million US$)
Table 67. India Endometriosis Therapies Market Share by Type (2015-2020)
Table 68. India Endometriosis Therapies Market Size by Application (2015-2020) (Million US$)
Table 69. India Endometriosis Therapies Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Endometriosis Therapies Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Endometriosis Therapies Market Share (2019-2020)
Table 72. Central & South America Endometriosis Therapies Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Endometriosis Therapies Market Share by Type (2015-2020)
Table 74. Central & South America Endometriosis Therapies Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Endometriosis Therapies Market Share by Application (2015-2020)
Table 76. AbbVie Company Details
Table 77. AbbVie Business Overview
Table 78. AbbVie Product
Table 79. AbbVie Revenue in Endometriosis Therapies Business (2015-2020) (Million US$)
Table 80. AbbVie Recent Development
Table 81. Eli Lilly Company Details
Table 82. Eli Lilly Business Overview
Table 83. Eli Lilly Product
Table 84. Eli Lilly Revenue in Endometriosis Therapies Business (2015-2020) (Million US$)
Table 85. Eli Lilly Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Product
Table 89. AstraZeneca Revenue in Endometriosis Therapies Business (2015-2020) (Million US$)
Table 90. AstraZeneca Recent Development
Table 91. Bayer Company Details
Table 92. Bayer Business Overview
Table 93. Bayer Product
Table 94. Bayer Revenue in Endometriosis Therapies Business (2015-2020) (Million US$)
Table 95. Bayer Recent Development
Table 96. Astellas Pharma Company Details
Table 97. Astellas Pharma Business Overview
Table 98. Astellas Pharma Product
Table 99. Astellas Pharma Revenue in Endometriosis Therapies Business (2015-2020) (Million US$)
Table 100. Astellas Pharma Recent Development
Table 101. Meditrina Pharmaceuticals Company Details
Table 102. Meditrina Pharmaceuticals Business Overview
Table 103. Meditrina Pharmaceuticals Product
Table 104. Meditrina Pharmaceuticals Revenue in Endometriosis Therapies Business (2015-2020) (Million US$)
Table 105. Meditrina Pharmaceuticals Recent Development
Table 106. Pfizer Company Details
Table 107. Pfizer Business Overview
Table 108. Pfizer Product
Table 109. Pfizer Revenue in Endometriosis Therapies Business (2015-2020) (Million US$)
Table 110. Pfizer Recent Development
Table 111. Neurocrine Biosciences Business Overview
Table 112. Neurocrine Biosciences Product
Table 113. Neurocrine Biosciences Company Details
Table 114. Neurocrine Biosciences Revenue in Endometriosis Therapies Business (2015-2020) (Million US$)
Table 115. Neurocrine Biosciences Recent Development
Table 116. Takeda Pharmaceutical Company Details
Table 117. Takeda Pharmaceutical Business Overview
Table 118. Takeda Pharmaceutical Product
Table 119. Takeda Pharmaceutical Revenue in Endometriosis Therapies Business (2015-2020) (Million US$)
Table 120. Takeda Pharmaceutical Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Endometriosis Therapies Market Share by Type: 2020 VS 2026
Figure 2. Hormonal Contraceptives Features
Figure 3. Gonadotropin-releasingHormone(Gn-RH)Agonists Features
Figure 4. Progestin Therapy Features
Figure 5. Aromatase Inhibitors Features
Figure 6. Global Endometriosis Therapies Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Endometriosis Therapies Report Years Considered
Figure 11. Global Endometriosis Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Endometriosis Therapies Market Share by Regions: 2020 VS 2026
Figure 13. Global Endometriosis Therapies Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Endometriosis Therapies Market Share by Players in 2019
Figure 16. Global Top Endometriosis Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Therapies as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Endometriosis Therapies Revenue in 2019
Figure 18. North America Endometriosis Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Endometriosis Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Endometriosis Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Endometriosis Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Endometriosis Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Endometriosis Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Endometriosis Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. AbbVie Revenue Growth Rate in Endometriosis Therapies Business (2015-2020)
Figure 27. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Eli Lilly Revenue Growth Rate in Endometriosis Therapies Business (2015-2020)
Figure 29. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. AstraZeneca Revenue Growth Rate in Endometriosis Therapies Business (2015-2020)
Figure 31. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Bayer Revenue Growth Rate in Endometriosis Therapies Business (2015-2020)
Figure 33. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Astellas Pharma Revenue Growth Rate in Endometriosis Therapies Business (2015-2020)
Figure 35. Meditrina Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Meditrina Pharmaceuticals Revenue Growth Rate in Endometriosis Therapies Business (2015-2020)
Figure 37. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Pfizer Revenue Growth Rate in Endometriosis Therapies Business (2015-2020)
Figure 39. Neurocrine Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Neurocrine Biosciences Revenue Growth Rate in Endometriosis Therapies Business (2015-2020)
Figure 41. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Takeda Pharmaceutical Revenue Growth Rate in Endometriosis Therapies Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed